Investment Newsletters

H.C. Wainwright

H.C. Wainwright Assumes Buy On OXiGENE, Reduces Price Target To $6

In a research note released today, H.C.

Editor Ben Weinberg — June 26, 2014, 9:10 AM EDT

H.C. Wainwright Initiates Buy On Cesca Therapeutics; Sets $5 Price Target

In a research noted released today, H.C.

Editor Ben Weinberg — June 26, 2014, 8:28 AM EDT

H.C. Wainwright Reiterates Buy On OncoSec Following YTD Results

In a research note issued this morning, H.C.

Ben Mahaney, Editor — June 19, 2014, 7:37 AM EDT

H.C. Wainwright Reiterates Buy On Insmed Incorporated, $30 PT

In a research note released today, H.C.

Ben Mahaney, Editor — June 18, 2014, 4:14 PM EDT

H.C. Wainwright Keeps ‘Buy’ On Ariad Following $200 Million Offering

In a research note issued today, H.C.

Ben Mahaney, Editor — June 17, 2014, 5:16 PM EDT

H.C. Wainwright Reiterates Buy On United Therapeutics

In a research note issued this morning, H.C.

Ben Mahaney, Editor — June 16, 2014, 12:47 PM EDT

Vertex Shares Will Outperform The Biotech Sector, Says H.C. Wainwright

In a research note released this morning, H.C.

Ben Mahaney, Editor — June 16, 2014, 12:25 PM EDT

H.C. Wainwright Initiates Coverage On EDAP At Buy, Announces $6 PT

In a research note issued this morning, H.C.

Ben Mahaney, Editor — June 16, 2014, 12:04 PM EDT

CTI BioPharma Reiterated With A Buy At H.C. Wainwright

In a research note issued this morning, H.C.

Ben Mahaney, Editor — June 13, 2014, 2:27 PM EDT

Celsion Corp. Reiterated With A Buy At H.C.Wainwright

H.C.

Ben Mahaney, Editor — June 11, 2014, 11:38 AM EDT

« 1 … 19 20 21